The Venture Codex Logo

The Venture Codex

Overview

Biotechnology company developing exosome-based therapeutics for diseases.

Total Raised

$143 M

Rounds

3

Links

Verticals

Biotechnology
Health Care
Pharmaceutical

Investment History

  1. Equity

    Feb 2021

    $95M

  2. Equity

    Mar 2019

    $2M

  3. Series B

    Sep 2018

    $46M

Team

Per Lundin

Chief Executive Officer & Co-Founder

David Lowe

Vice President Research

Peter Jones

Vice President of CMC

Charlotte-Maria Orphanou

Group Leader of DSP Development & Scale-Up